SCHEMBL8113040

SCHEMBL8113040

CC(C)Cc1ccc(/C=C\c2cccc(C(=O)O)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 5/20 0.61
▸ UNG P13051 1/20 0.49
▸ FBP1 P09467 1/20 0.48
▸ P4HB P07237 1/20 0.46
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ SRD5A1 P18405 1/20 0.45
▸ SRD5A2 P31213 1/20 0.45
▸ PTGS1 P23219 2/20 0.43
▸ PTGS2 P35354 2/20 0.43
▸ MEP1B Q16820 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ ALB P02768 1/20 0.43
▸ ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8112605 1.00 TTR (0.61) TTRUNGFBP1P4HBNPC1
SCHEMBL9372275 1.00 TTR (0.61) TTRUNGFBP1P4HBNPC1
SCHEMBL8121695 0.87 TTR (0.46) TTRNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL8121698 0.87 TTR (0.46) TTRNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL8120717 0.85 P4HB (0.51) TTRP4HBNPC1RAB9ASMN1; SMN2
SCHEMBL8114187 0.85 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL8114190 0.85 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL9373781 0.83 TTR (0.48) TTRRAB9AKMT2A
SCHEMBL9373774 0.83 TTR (0.48) TTRRAB9AKMT2A
SCHEMBL13926057 0.83 TTR (0.86) TTRUNGFBP1P4HBSRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0519353-B1 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them FUJISAWA PHARMACEUTICAL CO (JP) 2000-08-16 — — EP disclosed
US-5334716-A Preventing testosteron 5a-reductase mediated diseases; alopecia, acne, prostatism FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-08-02 — — US disclosed
EP-0519353-A2 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-12-23 — — EP disclosed
Send feedback